Stratophase wins

Published: 1-Feb-2010

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured £2.5m of follow-on funding from existing investor East Hill Management of Providence, Rhode Island in the US.

The additional investment will enable the company, a spin-out from Southampton University, to roll out its SpectroSens real-time monitoring technology, recruit key staff and move to larger premises.

The SpectroSens optical microchip technology is being developed for a number of applications in process measurement and bio-detection, including in-line monitoring of pharmaceutical manufacturing (both small molecule and bio-pharmaceuticals).

The company says a multinational pharmaceutical company is currently evaluating the system.

Stratophase is headed by ceo Dr Richard Williams.




You may also like